Company
Ahead Together
We unite science, technology and talent to get ahead of disease together.
Ahead Together
Getting ahead of disease is one of the most inspiring challenges there is on the planet.We aim to positively impact the health of 2.5 billion people by the end of the decade.
At a glance
GSK has a history in Canada that dates back to 1902. We currently employ approximately 1,628 full time employees across the country, providing a salary injection of $94 million into the Canadian economy.
Our leadership team
Find out more about our leadership team who have overall responsibility for delivering our ambition, strategy and culture.
View our policy positions
We have policies in place across GSK to ensure we meet the high standards we set ourselves as a company, and those that are expected of us externally.
Learn more about our views and our practices across a range of issues that are important to GSK, our patients and our stakeholders.
Latest press releases
- Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit for these patients
- GSK’s Nucala (mepolizumab) accepted for review by Health Canada for the treatment of COPD
- National survey reveals low understanding of shingles risk factors and lack of concern among those at increased risk
